Florida State Surgeon General Calls for Halt in the Use of COVID-19 mRNA Vaccines

This person should be neither a physician, nor someone with any kind of authority over anything whatsoever.

I'm sure this has nothing to do with politics and is all completely supported by science.

I mean you're only killing your own constituents. Keep it up and we'll have a supermajority.

"Quack! Quack! Quack quack quack; quack quack." -- Joseph Ladapo

I wonder what’s driving this guy to do such blatantly shady stuff like reporting from unreviewed research and editing the findings of studies.

Does he actually believe this shit, despite everything he learned in school? Is someone paying him? Is he doing this because he likes the national attention it’s getting him?

Summary:

The Florida State Surgeon General, Dr. Joseph A. Ladapo, has urged a pause in the use of Pfizer and Moderna COVID-19 mRNA vaccines, citing concerns about nucleic acid contaminants. In a letter to the FDA and CDC, he specifically pointed to the presence of Simian Virus 40 (SV40) promoter/enhancer DNA in these vaccines, raising worries about potential risks associated with DNA integration into human cells. Dr. Ladapo emphasized that the FDA has not provided evidence of conducting assessments on these risks, as recommended in their own 2007 guidelines. He underscores the unique and heightened risk of DNA integration, stating that if not assessed, mRNA COVID-19 vaccines may not be suitable for human use. The Surgeon General encourages healthcare providers to prioritize non-mRNA COVID-19 vaccines and treatment. Dr. Ladapo commits to ongoing research assessment, emphasizing transparency and scientific integrity in providing updates to the public.

The Hypocrite’s Oath:

First, do harm.

From the article, not in OP's summary:

In 2007, the FDA published guidance on regulatory limits for DNA vaccines in the Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications (Guidance for Industry). In this Guidance for Industry, the FDA outlines important considerations for vaccines that use novel methods of delivery regarding DNA integration, specifically:

• DNA integration could theoretically impact a human’s oncogenes – the genes which can transform a healthy cell into a cancerous cell.

• DNA integration may result in chromosomal instability.

• The Guidance for Industry discusses biodistribution of DNA vaccines and how such integration could affect unintended parts of the body including blood, heart, brain, liver, kidney, bone marrow, ovaries/testes, lung, draining lymph nodes, spleen, the site of administration and subcutis at injection site.

On December 14, 2023, the FDA provided a written response providing no evidence that DNA integration assessments have been conducted to address risks outlined by the FDA themselves in 2007. Based on the FDA’s recognition of unique risks posed by DNA integration, the efficacy of the COVID-19 mRNA vaccine’s lipid nanoparticle delivery system, and the presence of DNA fragments in these vaccines, it is essential to human health to assess the risks of contaminant DNA integration into human DNA. The FDA has provided no evidence that these risks have been assessed to ensure safety. As such, Florida State Surgeon General Dr. Joseph A. Ladapo has released the following statement:

“The FDA’s response does not provide data or evidence that the DNA integration assessments they recommended themselves have been performed. Instead, they pointed to genotoxicity studies – which are inadequate assessments for DNA integration risk. In addition, they obfuscated the difference between the SV40 promoter/enhancer and SV40 proteins, two elements that are distinct.

DNA integration poses a unique and elevated risk to human health and to the integrity of the human genome, including the risk that DNA integrated into sperm or egg gametes could be passed onto offspring of mRNA COVID-19 vaccine recipients. If the risks of DNA integration have not been assessed for mRNA COVID-19 vaccines, these vaccines are not appropriate for use in human beings.

Providers concerned about patient health risks associated with COVID-19 should prioritize patient access to non-mRNA COVID-19 vaccines and treatment. It is my hope that, in regard to COVID-19, the FDA will one day seriously consider its regulatory responsibility to protect human health, including the integrity of the human genome.”